Company Active LTD

Company profile

Bond Digital Health Ltd

Bond Digital Health Ltd is a UK company with status active founded in 2015.

CRN
09628474
Founded
2015
Age
10

Overview

Legal name
BOND DIGITAL HEALTH LTD
Region
Unknown
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

2 events
18 Nov
2024

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

Insolvency

LIQ03 | Transaction MzQ0Mjg0Nzc1NmFkaXF6a2N4 | Paper/PDF filed

Published 19 Nov 2024 10:40

08 Jun
2015

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2018
Funded years
2018, 2020, 2021
Age at first award
2 years

Projects

2021 Feasibility Studies

Gold nanorod diagnostic test and data management system for detection and control of bovine tuberculosis

1 Feb 2021 to 30 Apr 2023

Awarded
£95,589
Total cost £136,556

Tuberculosis (TB) is a bacterial infection that mainly affects the lungs, causing a general state of illness, coughing and eventually death. Bovine tuberculosis (bTB) is caused by a particular bacterium that affects cows but can be passed on to practically all mammals, including humans. The usual route of infection is through the inhalation of infected dr...

2020 Feasibility Studies Lead participant

Web Connected Platform for Capturing COVID-19 Rapid Test Data to Support Decision-Makers in Real-Time

1 Jun 2020 to 31 Mar 2021

Awarded
£74,755
Total cost £74,755

Accurate, real-time data is essential in the ongoing fight against the coronavirus. Diagnostic testing is being held up as the key to understanding and slowing the spread of the virus. The approach has already had an impact in some countries during this outbreak and was endorsed by the WHO director-general, who urged countries to ramp up testing activity....

2018 Feasibility Studies Lead participant

A digital solution for patient-centred management of Chronic Obstructive Pulmonary Disease [METIS]

1 Jun 2018 to 28 Feb 2019

Awarded
£68,583
Total cost £97,976

"Chronic Obstructive Pulmonary Disease (COPD) is a common, progressively disabling disease characterised by airflow obstruction in the lung and commonly associated with smokers. The World Health Organisation (WHO) estimated that over 384 million people were affected worldwide in 2010, with 65 million people estimated to have moderate to severe disease. Th...

Product types

Feasibility Studies